226 related articles for article (PubMed ID: 15204165)
1. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
Vereecken P; Monsieur E; Petein M; Heenen M
J Dermatolog Treat; 2004 Apr; 15(2):120-1. PubMed ID: 15204165
[No Abstract] [Full Text] [Related]
2. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
Marks R; Owens M; Walters SA;
Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
[No Abstract] [Full Text] [Related]
4. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.
Micali G; De Pasquale R; Caltabiano R; Impallomeni R; Lacarrubba F
J Dermatolog Treat; 2002 Sep; 13(3):123-7. PubMed ID: 12227875
[TBL] [Abstract][Full Text] [Related]
5. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
Kocabaş E; Ermertcan AT; Bilaç C; Bilaç DB; Temiz P
Cutan Ocul Toxicol; 2010 Dec; 29(4):300-2. PubMed ID: 20684662
[TBL] [Abstract][Full Text] [Related]
6. Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream.
Ferreres JR; Macaya A; Jucglà A; Muniesa C; Prats C; Peyrí J
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):877-8. PubMed ID: 16898919
[No Abstract] [Full Text] [Related]
7. Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up.
Vidal D; Matías-Guiu X; Alomar A
Arch Dermatol; 2007 Feb; 143(2):266-8. PubMed ID: 17310012
[No Abstract] [Full Text] [Related]
8. Topical treatment of basal cell carcinoma with the immune response modifier imiquimod.
Papakostas D; Stockfleth E
Future Oncol; 2015 Nov; 11(22):2985-90. PubMed ID: 26450707
[TBL] [Abstract][Full Text] [Related]
9. Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure.
Harting M; Vujevich J; Goldberg LH
Dermatol Surg; 2007 Dec; 33(12):1516-9. PubMed ID: 18076623
[No Abstract] [Full Text] [Related]
10. Localized pemphigus foliaceus induced by topical imiquimod treatment.
Lin R; Ladd DJ; Powell DJ; Way BV
Arch Dermatol; 2004 Jul; 140(7):889-90. PubMed ID: 15262711
[No Abstract] [Full Text] [Related]
11. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
Shulstad RM
Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
[TBL] [Abstract][Full Text] [Related]
12. Eradication of basal cell cancer in an HIV positive patient with topical imiquimod.
Scott DR
J Drugs Dermatol; 2004; 3(6):602. PubMed ID: 15624742
[No Abstract] [Full Text] [Related]
13. Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod.
Santiago Sánchez-Mateos D; Goiriz Valdés R; Daudén Tello E
Clin Exp Dermatol; 2010 Mar; 35(2):199-200. PubMed ID: 19486047
[No Abstract] [Full Text] [Related]
14. Imiquimod - Its role in the treatment of cutaneous malignancies.
Bubna AK
Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
[TBL] [Abstract][Full Text] [Related]
15. Has imiquimod 5% cream a role in the management of recurrent basal cell carcinoma?
RUIZ-VILLAVERDE R; SANCHEZ-CANO D; BURKHARDT-PEREZ P; SINTES RN
Eur J Dermatol; 2009; 19(5):481-3. PubMed ID: 19527989
[TBL] [Abstract][Full Text] [Related]
16. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
Akkilic-Materna M; Massone C; Komericki P
Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
[TBL] [Abstract][Full Text] [Related]
18. 'Rub on' treatment for basal-cell carcinoma.
Kerr C
Lancet Oncol; 2002 Apr; 3(4):201. PubMed ID: 12067676
[No Abstract] [Full Text] [Related]
19. Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.
Turan A; Saricaoglu H; Baskan EB; Toker SC; Tunali S
Int J Dermatol; 2009 Feb; 48(2):214-5. PubMed ID: 19200213
[No Abstract] [Full Text] [Related]
20. Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream.
Yang JQ; Chen XY; Engle MY; Wang JY
Dermatol Ther; 2015; 28(4):243-7. PubMed ID: 25754701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
